| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/13/2002 | CN1340050A Heterocyclic benzenesulphonamide compounds as bradykinine antagonists |
| 03/13/2002 | CN1340046A β－丙氨酸衍生物 β- alanine derivatives |
| 03/13/2002 | CN1340045A 5-HTIF agonists |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1339965A Combinations of formoterol and fluticasone propionate for asthma |
| 03/13/2002 | CN1339963A Spontaneously dispersible N-benzoyl staurosporine compositions |
| 03/13/2002 | CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances |
| 03/13/2002 | CN1339312A Wound plaster of yannan Baiyao and its preparing method |
| 03/13/2002 | CN1080718C Vitamin D amine and amine derivatives |
| 03/12/2002 | US6355689 Antiinflammatory agents |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/12/2002 | US6355658 Coumarin derivatives, methods of preparation and application as medicines |
| 03/12/2002 | US6355650 Leukocyte antiadhesion agents |
| 03/12/2002 | US6355646 Immunology treatment of inflammatory conditions and immune disorders septic shock |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355617 Peptide derivatives |
| 03/12/2002 | US6355483 Antisense nucleotides for use in the treatment of leukemia |
| 03/12/2002 | US6355275 Delivering an embolic agent formulation to a blood vessel to fill or plug the blood vessel and/or encourage clot formation so that blood flow through the vessel is reduced or ceases |
| 03/12/2002 | US6355265 Over-coated chewing gum formulations |
| 03/12/2002 | US6355258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form |
| 03/12/2002 | US6355252 Antiinflammatory agents |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2016235C Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 03/07/2002 | WO2002018623A2 Methods and reagents for protease inhibition |
| 03/07/2002 | WO2002018593A2 Modulation of fas and fasl expression |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018540A2 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | WO2002018450A1 New cross-linked derivatives of hyaluronic acid |
| 03/07/2002 | WO2002018445A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | WO2002018404A2 Nucleoside derivatives for the treatment of hepatitis c |
| 03/07/2002 | WO2002018395A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | WO2002018380A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | WO2002018379A2 7-oxo pyridopyrimidines |
| 03/07/2002 | WO2002018378A1 Pyrrolidine derivatives and their use as chymase inhibitor |
| 03/07/2002 | WO2002018374A1 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors |
| 03/07/2002 | WO2002018373A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof |
| 03/07/2002 | WO2002018371A1 Nucleoside metabolism inhibitors |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | WO2002018341A2 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | WO2002018340A1 GEM-SUBSTITUTED α v β 3 INTEGRIN ANTAGONISTS |
| 03/07/2002 | WO2002018335A1 Cyclic amine derivatives |
| 03/07/2002 | WO2002018330A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 03/07/2002 | WO2002018324A2 Immunoregulatory compounds, derivatives thereof and their use |
| 03/07/2002 | WO2002018320A2 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 03/07/2002 | WO2002017953A2 Thrombomodulin analogs for use in recovery of signal cord injury |
| 03/07/2002 | WO2002017938A1 Use of extracts of the cassia alata plant |
| 03/07/2002 | WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | WO2002017914A2 Fused pyrrolocarbazoles against inflammation |
| 03/07/2002 | WO2002017892A2 Water-dispersible encapsulated sterols |
| 03/07/2002 | WO2002017881A2 Transdermal pharmaceutical delivery composition |
| 03/07/2002 | WO2002017857A2 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | WO2001090103A9 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 03/07/2002 | WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | WO2001060983A3 Treatment for bone disorders |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | WO2001056983A3 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001043692A3 SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001028591A3 Injection vehicle for polymer-based formulations |
| 03/07/2002 | WO2001023377A3 Polymorphic salt |
| 03/07/2002 | WO2001021162A3 Treating allergic and inflammatory conditions using desloratadine |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | US20020028973 Bactericides, antioxidants, and antiinflammatory agents |
| 03/07/2002 | US20020028953 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 03/07/2002 | US20020028949 Synthesis of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one |
| 03/07/2002 | US20020028945 Non-steroidal antiinflammatory agent; enzyme sub-type specific; inhibits prostaglandin and/or leukotriene production |
| 03/07/2002 | US20020028934 Process for preparing benzoxazin-4-one polymer conjugates |
| 03/07/2002 | US20020028933 Thioamide derivatives |
| 03/07/2002 | US20020028851 Guanylhydrazones and their use to treat inflammatory conditions |
| 03/07/2002 | US20020028848 Administering orally 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE); anticoagulants; cardiovascular, respiratory, gastrointestinal, nervous and psyiatric disorders; autoimmune disease; antiinflammatory agents; bactericides; viricides |
| 03/07/2002 | US20020028841 Thienopyrrolidinones |
| 03/07/2002 | US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 03/07/2002 | US20020028831 Phenylpyridine derivatives useful as phosphodiesterase inhibitors |
| 03/07/2002 | US20020028828 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | US20020028826 HMG-CoA reductase inhibitors and method |
| 03/07/2002 | US20020028817 Platelet derived growth factors (PDGF); 1,2-dimethyl-6-(2-thiophene)imidazolo(5,4-g)quinoxaline preparations for example; use treating proliferative malignant and non-malignant diseases; stents |
| 03/07/2002 | US20020028815 Novel multicyclic compounds and the use thereof |
| 03/07/2002 | US20020028812 Phenylalanine derivatives |
| 03/07/2002 | US20020028803 Controlling cell apoptosis |
| 03/07/2002 | US20020028797 Therapy for metabolism diseases; dietetics; antidiabetic agents |
| 03/07/2002 | US20020028782 Cardiovascular disorders; nervous system disorders |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | US20020028772 Modulation of metabolism |
| 03/07/2002 | US20020028449 26 Human secreted proteins |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028238 Orally administration to provide a blood plasma concentration profile of celecoxib of at least about 250 mg/ml in not more than about 30 minutes |
| 03/07/2002 | US20020028227 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 03/07/2002 | US20020028199 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC) |